Eloxx Pharmaceuticals, Inc. (ELOX): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$66.0K
Year ended 2022-12-31
+18.2%
3-year compound annual growth
-22.6%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $66.0K | -25.8% | 2023-03-31, From 2022-01-01 |
| 2021-12-31 | $89.0K | n/a | 2023-03-31, From 2021-01-01 |
| No annual figure between 2019-12-31 and 2021-12-31. | |||
| 2019-12-31 | $40.0K | -83.0% | 2022-03-30, From 2019-01-01 |
| 2018-12-31 | $235.0K | -0.8% | 2021-03-12, From 2018-01-01 |
| 2017-12-31 | $237.0K | +558.3% | 2020-03-06, From 2017-01-01 |
| 2016-12-31 | $36.0K | +260.0% | 2019-03-14, From 2016-01-01 |
| 2015-12-31 | $10.0K | n/a | 2018-03-16, From 2015-01-01 |
| No annual figure between 2014-06-30 and 2015-12-31. | |||
| 2014-06-30 | $3.2K | +149.3% | 2016-10-13, From 2013-07-01 |
| 2013-06-30 | $1.3K | -71.3% | 2015-10-09, From 2012-07-01 |
| 2012-06-30 | $4.5K | +120.2% | 2014-09-29, From 2011-07-01 |
| 2011-06-30 | $2.0K | +81.5% | 2013-09-11, From 2010-07-01 |
| 2010-06-30 | $1.1K | n/a | 2012-10-26, From 2009-07-01 |